Pfizer will briefly scale back its deliveries to Europe of its vaccine towards COVID-19 whereas it upgrades its manufacturing capability, the Norwegian Institute of Public Well being mentioned on Friday.
“We acquired this message in the present day somewhat earlier than 10am (0900 GMT). We had anticipated 43,875 vaccines doses from Pfizer in week 3 (subsequent week). Now it seems that we’ll get 36,075 doses,” the Norwegian Institute of Public Well being (FHI) mentioned in an announcement.
The discount in deliveries is because of Pfizer limiting output in order that it could actually improve manufacturing capability to 2 billion vaccine doses per yr from 1.3 billion at the moment, the FHI mentioned.
“This momentary discount will have an effect on all European nations,” mentioned the FHI. “It’s as but not exactly clear how very long time it’s going to take earlier than Pfizer is as much as most manufacturing capability once more.”